BRIEF-Immunovaccine announces positive phase 1 topline data for DepoVax-based respiratory syncytial virus vaccine candidate

Thu Oct 13, 2016 7:16am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

Oct 13 (Reuters) - Immunovaccine Inc :

* Immunovaccine announces positive phase 1 topline data for depovax(tm)-based respiratory syncytial virus vaccine candidate

* Immunovaccine Inc - vaccine had a positive safety profile and was well tolerated with no serious adverse events among all study participants Source text for Eikon: Further company coverage: